NASDAQ:CTSO
Cytosorbents Corporation Stock News
$0.97
+0.101 (+11.69%)
At Close: May 17, 2024
So far Friday, February 28, NASDAQ is up 8.15% and the S&P is up 3.2%. Let’s take a look at
So far Tuesday, February 25, NASDAQ is down -5.98% and the S&P is down -5.61%. Here are this morning’s most
Contrasting Cytosorbents (NASDAQ:CTSO) and Axonics Modulation Technologies (NASDAQ:AXNX)
07:28am, Monday, 24'th Feb 2020
Cytosorbents (NASDAQ:CTSO) and Axonics Modulation Technologies (NASDAQ:AXNX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the stren
TSLA, PLUG among premarket gainers
02:20pm, Wednesday, 19'th Feb 2020
Viveve Medical (NASDAQ:VIVE) +35%.Quad/Graphics (NYSE:QUAD) +24% on Q4 results.Myomo (NYSEMKT:MYO) +21% on expanded MyoPro access.Cemtrex (NASDAQ:CETX) +18% on Q1 results.Enphase Energy (NASDAQ:ENP
The "Apheresis Market by Product [Device (Centrifugation, Membrane Separation) Disposable], Procedure (Donor, Therapeutic), Application (Plasmapheresis, Plateletpheresis), Technology, End-User (Hospit
The "Apheresis Market by Product [Device (Centrifugation, Membrane Separation) Disposable], Procedure (Donor, Therapeutic), Application (Plasmapheresis, Plateletpheresis), Technology, End-User (Hospit
$2.7Bn Apheresis Market by Product, Procedure, Application, Technology, End-user and Region - Forecast to 2025
10:38am, Monday, 10'th Feb 2020
Dublin, Feb. 10, 2020 -- The "Apheresis Market by Product , Procedure (Donor, Therapeutic), Application.
Analysts See 20% Upside to These 3 "Strong Buy" Tech Stocks
01:20pm, Sunday, 02'nd Feb 2020
While 2019’s market performance broke records, Wall Street is less optimistic about 2020. The pros foresee those gains leveling off in coming months and a